Intersect Labs is a synthetic biology company developing biological manufacturing platforms for complex molecules. Founded in 2022, the company applies advances in DNA-based computing and synthetic biology to reduce the cost and complexity of producing specialty chemicals and biologics. The company operates as a private US-based biotech firm focused on making biomanufacturing more accessible and scalable for pharmaceutical and industrial applications.
1 open now, 1 first appeared in the last 30d.
| Title ↕ | Location ↕ | Posted ↓ |
|---|---|---|
| Insurance Risk Management Lead | United States | May 6 |